Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Deroisy

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Maturitas|December 22, 1999
Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal womenJ Y Reginster, R Deroisy, I Paul, et al.
Revue Medicale De Liege|December 1, 1988
[Paget's disease 100 years after Sir Paget]M P Lecart, D Denis, R Deroisy, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 3, 2002
Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trialJ Y Reginster, R Deroisy, M Dougados, et al.
Calcified Tissue International|November 1, 1992
Minimal levels of serum estradiol prevent postmenopausal bone lossJ Y Reginster, N Sarlet, R Deroisy, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 1, 1993
Acute biochemical variations induced by four different calcium salts in healthy male volunteersJ Y Reginster, D Denis, V Bartsch, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|June 1, 1989
[Hypocalcemia induced in patients with Paget's disease by nasal salmon calcitonin. Effects of anti-calcitonin salmine antibodies]J Y Reginster, S Almer, S Gaspar, et al.
Revue Medicale De Liege|January 15, 1989
[Comparison of the osteoprotective effects of orally administered equine conjugated estrogens and percutaneous 17 beta-estradiol]J Y Reginster, N Sarlet, R Deroisy, et al.
Annals of the Rheumatic Diseases|January 1, 1993
Paget's disease of bone treated with a five day course of oral tiludronateJ Y Reginster, M P Lecart, R Deroisy, et al.
Calcified Tissue International|June 1, 1995
Prevention of postmenopausal bone loss by rectal calcitoninJ Y Reginster, I Jupsin, R Deroisy, et al.
Clinical Rheumatology|March 1, 1995
Long-term performance in vitro and in vivo of dual-energy X-ray absorptiometryJ Y Reginster, R Deroisy, B Zegels, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Maturitas|December 22, 1999
Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal womenJ Y Reginster, R Deroisy, I Paul, et al.
Revue Medicale De Liege|December 1, 1988
[Paget's disease 100 years after Sir Paget]M P Lecart, D Denis, R Deroisy, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 3, 2002
Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trialJ Y Reginster, R Deroisy, M Dougados, et al.
Calcified Tissue International|November 1, 1992
Minimal levels of serum estradiol prevent postmenopausal bone lossJ Y Reginster, N Sarlet, R Deroisy, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 1, 1993
Acute biochemical variations induced by four different calcium salts in healthy male volunteersJ Y Reginster, D Denis, V Bartsch, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|June 1, 1989
[Hypocalcemia induced in patients with Paget's disease by nasal salmon calcitonin. Effects of anti-calcitonin salmine antibodies]J Y Reginster, S Almer, S Gaspar, et al.
Revue Medicale De Liege|January 15, 1989
[Comparison of the osteoprotective effects of orally administered equine conjugated estrogens and percutaneous 17 beta-estradiol]J Y Reginster, N Sarlet, R Deroisy, et al.
Annals of the Rheumatic Diseases|January 1, 1993
Paget's disease of bone treated with a five day course of oral tiludronateJ Y Reginster, M P Lecart, R Deroisy, et al.
Calcified Tissue International|June 1, 1995
Prevention of postmenopausal bone loss by rectal calcitoninJ Y Reginster, I Jupsin, R Deroisy, et al.
Clinical Rheumatology|March 1, 1995
Long-term performance in vitro and in vivo of dual-energy X-ray absorptiometryJ Y Reginster, R Deroisy, B Zegels, et al.
Pageof 5